Replies to post #7505 on GTC Biotherapeutics (fka GTCB)

[kris_kade]

while your thesis has merit, you forgot to include VOLUME

Most of the GTCB followers are not sitting on couple of hundred shares..rather in thousands hoping for 3x to 5x return on short term basis.

On the other hand, 50K shares on ZGEN is not a small potato.

So strictly on a point move, GTCB has better return than ZGEN based on volume alone

[WID]

Top-line data from the US ATryn trial may not be available until mid Feb. (Feb. 12 or 13). That's what I am guessing... I hope that I am wrong.

Have a great week!
Thanks!
WID